NCT00082784 2014-12-23Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell NeoplasmsNational Cancer Institute (NCI)Phase 1 Completed93 enrolled
NCT00047203 2013-01-16Flavopiridol in Treating Patients With Relapsed or Refractory Multiple MyelomaNational Cancer Institute (NCI)Phase 2 Completed35 enrolled